Brief: Oasis Management Raises Stake In M3 Inc To 9.48% From 8.46%, Regulatory Filing Shows
Brief: Oasis Management Raises Stake In M3 To 7.4% From 6.26%, Filing Shows
Brief: Oasis Management Holds 5.03% Stake In M3, Filing Shows
Table: M3 -Q1 group results (IFRS)
Brief: M3 Inc - To Buy Up To 20 Million Shares, 3.00% Of Outstanding Shares
Table: M3 -2025/26 group results (IFRS)
Table: M3 -9-MTH group results (IFRS)
Table: M3 6-MTH group results (IFRS)
Table: M3 -Q1 group results (IFRS)
Brief: Oasis Japan Strategic Fund Y Ltd Owns 1.2% Stake In M3 Inc, Shareholder Meeting Notice Shows
Brief: M3 Inc - To Buy Back Up To 2.95% Of Own Shares Worth 20 Billion Yen
Table: M3 -2024/25 group results (IFRS)
Table: M3 -9-MTH group results (IFRS)
Brief: Medirom Healthcare Technology's Unit, Medirom Mother Labs, Raises An Aggregate Total Of JPY260.3 Million In Its Series A Financing Round
Brief: Medirom Healthcare Technologies Joins Medirom Mother Labs' Series A Financing Round
Brief: M3 - Notice Concerning Commencement Of Tender Offer For Shares Of Elan Corporation, And Execution Of Capital And Business Tie-Up Agreement
Table: M3 -Q1 group results (IFRS)
Table: M3 -2023/24 group results (IFRS)
Dai-ichi Life CEO expects unsolicited takeovers to become common practice in Japan